| Transaction Date | Recipient | Shares | Type | Price | Value |
|---|
Atossa Therapeutics
Based on disclosure changes, sentiment, insider trading and news impact we give a rating of 9/10.
Atossa Therapeutics, Inc. operates as a clinical-stage pharmaceutical company. It focuses on the development of novel therapeutics and delivery methods for the treatment of breast cancer and other breast conditions. The company was founded by Steven C. Quay and Shu Chih Chen in December 2008.
Ticker: ATOS
Sector: Health Technology
Industry: Medical Specialties
SEC Central Index Key (CIK): 1488039
Employees: 6
Exchange: NASDAQ
Auditor Opinion:
You must Login to see Language Changes
Disclosure Language changes
You must Login to see analysis
Red Flags
We weren't able to import Fundamental data from the SEC disclosure.
There were no Red Flags found
Fundamentals
We weren't able to import Fundamental data from the SEC disclosure.
News
DXP Enterprises Reports Third Quarter 2020 Results
6th November 2020
17 Arrested For Running Fake Call Centre In Delhi: Police
6th November 2020
Ubiquiti Inc. Reports First Quarter Fiscal 2021 Financial Results
6th November 2020